Company Cerenis Therapeutics CINNOBER BOAT
Equities
0RAG
FR0012616852
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
Jun. 14 | Abionyx: positive response from FDA, share price rises | CF |
Jun. 13 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
Business Summary
At the end of 2023, the company boasted a portfolio of 3 products in clinical development.
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Research
100.0
%
| 5 | 100.0 % | 5 | 100.0 % | -11.65% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 5 | 100.0 % | 5 | 100.0 % | -11.65% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
Director of Finance/CFO | - | 08-04-30 | |
Renee Benghozi
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-08 |
Chief Operating Officer | - | - | |
Laurent Guerci
PRN | Corporate Officer/Principal | - | 23-07-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Martinez
BRD | Director/Board Member | 54 | - |
Christian Chavy
BRD | Director/Board Member | 75 | 15-02-05 |
Cyrille Tupin
CEO | Chief Executive Officer | 48 | 06-12-31 |
Laura Coruzzi
BRD | Director/Board Member | 71 | 15-05-26 |
Karen Noël
BRD | Director/Board Member | 51 | 17-06-08 |
Emmanuel Huynh
CHM | Chairman | 54 | 19-08-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,459,012 | 22,076,290 ( 68.01 %) | 253,928 ( 0.7823 %) | 68.01 % |
Company contact information
ABIONYX Pharma SA
33-43, avenue Georges Pompidou Bâtiment D2
31130, Balma
+33 5 62 24 97 06
http://www.abionyx.comSector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.90% | 122B | |
+19.12% | 113B | |
+8.24% | 22.84B | |
-20.19% | 20.72B | |
-16.19% | 16.51B | |
-13.11% | 16.39B | |
-44.35% | 15.83B | |
+2.50% | 13.49B | |
+73.37% | 11.67B |
- Stock Market
- Equities
- ABNX Stock
- 0RAG Stock
- Company Cerenis Therapeutics